CP ALL PCL (CPALL) Earnings: 3Q Net Income Surpasses Estimates at 6.60 Billion Baht

CP ALL PCL on Smartkarma

Analysts on Smartkarma, like Angus Mackintosh, are upbeat about CP ALL PCL. In a recent report titled “CP ALL (CPALL TB) – Stimulus Beneficiary,” Angus highlights the company’s anticipated gains from the government’s copayment stimulus program, launching in October. CP ALL stands to benefit directly through Makro, a supplier to mom-and-pop stores, and indirectly through 7-Eleven. The report underscores CP ALL’s positive outlook for growth in the second half of 2025, driven by promotions, government support, and improved margins from a better product mix. Additionally, 7-Eleven’s expansion plans and focus on larger stores with more product variety further reinforce the favorable sentiment towards CP ALL.

A look at CP ALL PCL Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

CP ALL PCL, a leading operator of convenience store chains in Thailand and China, has been assigned Smartkarma Smart Scores that indicate a positive long-term outlook. With a strong emphasis on growth and momentum, CP ALL PCL is positioned to capitalize on opportunities for expansion and increased market share. The company’s high Growth and Momentum scores suggest a promising future in terms of business development and performance.

While the Value and Dividend scores are moderate, CP ALL PCL‘s resilience score indicates a stable foundation to weather challenges and sustain its operations. Overall, the Smartkarma Smart Scores paint a picture of a company with a robust growth trajectory and momentum in the market, signaling potential for long-term success and profitability.

### CP ALL PCL operates convenience store chains in Thailand and China. The Company also owns and operates a department store chain located primarily in Shanghai city and Chongqing city of China. ###

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma